Abstract
An unusual case of bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during treatment with granulocyte colony-stimulating factor (G-CSF) is reported. The possible relationship between G-CSF therapy and pyoderma gangrenosum, as well as the beneficial effect of cyclosporin A therapy, is discussed.
MeSH terms
-
Aged
-
Cyclosporine / therapeutic use*
-
Granulocyte Colony-Stimulating Factor / adverse effects*
-
Granulocyte Colony-Stimulating Factor / therapeutic use*
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Male
-
Myelodysplastic Syndromes / complications*
-
Myelodysplastic Syndromes / drug therapy*
-
Pyoderma Gangrenosum / chemically induced*
-
Pyoderma Gangrenosum / drug therapy*
-
Skin Diseases, Vesiculobullous / chemically induced*
-
Skin Diseases, Vesiculobullous / drug therapy*
Substances
-
Immunosuppressive Agents
-
Granulocyte Colony-Stimulating Factor
-
Cyclosporine